Literature DB >> 27986632

Structural insight into mode of binding of Meropenem to CTX-M-15 type β-lactamase.

Lubna Maryam1, Asad U Khan2.   

Abstract

Among Enterobacteriaceae, CTX-M type extended spectrum beta lactamase confers potent hydrolytic activity against cephalosporin group of antibiotics. Strains producing CTX-M type beta lactamase enzymes, show high level of resistance against cefotaxime. Therefore carbapenem antibiotics are used against beta lactamase producing strains. Hence, this study was designed to understand an insight of molecular basis of CTX-M-15 interaction with meropenem, and its effect on CTX-M-15 efficiency. Clinical strain of Enterobacter cloacae (EC-15) was used to clone blaCTX-M-15 gene in E.coli BL21cells. The protein was then expressed and purified. Results showed that CTX-M-15 producing strains are susceptible to meropenem. It quenches the fluorescence of CTX-M-15 spontaneously with binding constant of the order of 103M-1. Meropenem binds on the active site of CTX-M-15, hydrogen bonded with four common amino acid residues of cefotaxime binding site, as revealed by molecular docking studies. Conformational change in the structure of CTX-M-15 was observed upon meropenem binding by CD spectroscopy. The catalytic efficiency of CTX-M-15 was decreased up to 4 times upon meropenem binding. Docking study shows that few amino acids of active site of enzyme are also involved in meropenem binding, hence substrate is difficult to bind on active site properly and does not get hydrolysed. Moreover, meropenem binding induces structural changes in CTX-M-15, making the enzyme less efficient.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antibiotic resistance; Beta-lactamase; Fluorescence quenching; Meropenem; Molecular docking

Mesh:

Substances:

Year:  2016        PMID: 27986632     DOI: 10.1016/j.ijbiomac.2016.12.032

Source DB:  PubMed          Journal:  Int J Biol Macromol        ISSN: 0141-8130            Impact factor:   6.953


  3 in total

1.  A mechanistic approach to prove the efficacy of combination therapy against New Delhi metallo-β-lactamases producing bacterial strain: a molecular and biochemical approach.

Authors:  Lubna Maryam; Abid Ali; Shamsi Khalid; Asad U Khan
Journal:  Eur J Med Res       Date:  2020-06-03       Impact factor: 2.175

2.  Significant role of Asn-247 and Arg-64 residues in close proximity of the active site in maintaining the catalytic function of CTX-M-15 type β-lactamase.

Authors:  Lubna Maryam; Shamsi Khalid; Abid Ali; Asad U Khan
Journal:  RSC Adv       Date:  2019-02-12       Impact factor: 4.036

3.  Synergistic Effect of Doripenem and Cefotaxime to Inhibit CTX-M-15 Type β-Lactamases: Biophysical and Microbiological Views.

Authors:  Lubna Maryam; Asad U Khan
Journal:  Front Pharmacol       Date:  2017-07-05       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.